Refined By:
Subject:  probucol
Fulltext:  No Fulltext

Results 1-6 of 6 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
126-Nov-2019Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine modelArmin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević ; Hani Al-Salami
2Dec-2019Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine modelArmin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami
31-Nov-2018Eudragit-based microcapsules of probucol with a gut-bacterial processed secondary bile acidArmin Mooranian; Nassim Zamani; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Hani Al-Salami
41-Jan-2015Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro studyMooranian A.; Negrulj R.; Momir Mikov ; Svetlana Goločorbin-Kon ; Arfuso F.; Al-Salami H.
51-Jan-2019Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic miceMooranian A.; Zamani N.; Takechi R.; Al-Sallami H.; Momir Mikov ; Svetlana Goločorbin-Kon ; Božica Kovačević; Arfuso F.; Al-Salami H.
61-Feb-2019Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatmentMooranian A.; Zamani N.; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Arfuso F.; Al-Salami H.